Is CRISPR safe? Genome editing gets its first FDA scrutiny

Advisors to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease. Advisors to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease.

Related Keywords

San Marcos ,California ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Boston ,Massachusetts ,Tennessee ,Memphis ,Pennsylvania ,Switzerland ,San Francisco ,Mark Walters ,Meletios Verras Getty ,Tosin Ola ,Samira Kiani ,Akshay Sharma ,University Of Pittsburgh School Medicine ,University Of California ,Jude Children Research Hospital In Memphis ,Shell ,Vertex Pharmaceuticals ,Drug Administration ,Pittsburgh School ,Jude Children ,Research Hospital ,Bluebird Bio ,Sickle Cell Warriors ,